EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Pediatric Non‐Rhabdomyosarcoma Soft‐Tissue Sarcomas of the Extremities

Mikaela H Sullivan iD, Lainey G Bukowiec iD, Wendy Allen-Rhoades iD, Peter J Schoettler iD, Nadia N Laack iD, Anita Mahajan, Peter S Rose, Matthew T Houdek iD

Journal of Surgical Oncology · 2026

DOI: 10.1002/jso.70350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Mikaela H Sullivan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Sarcoma, Extremities, Soft Tissue Neoplasms. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Non‐rhabdomyosarcoma soft tissue sarcomas (NRSTS) account for less than 4% of pediatric cancers. Treatment and outcomes have been described in adults, but pediatric data are lacking. The purpose of this study is to review our institution's outcomes of extremity NRSTS in pediatric patients.

Methods

Ninety‐eight (56 male: 42 female) pediatric patients with NRSTS of the extremity at our institution were reviewed. Mean age at diagnosis was 11 ± 5 years, and mean follow‐up was 12 ± 10 years. The most common diagnosis was synovial sarcoma (27%), and 60% were high‐grade.

Results

Treatment included surgical resection in all patients, with 33% receiving radiation and 37% receiving systemic therapy. 20‐year local recurrence‐ (LRFS) and metastatic disease‐free survival (MDFS) were 91% and 91%, respectively, with 92% disease specific survival (DSS). High grade tumors were associated with lower LRFS ( p = 0.02) and DSS ( p = 0.03). Tumor size < 5 cm demonstrated improved MDFS ( p = 0.03), and stage 3 tumors showed worse MDFS ( p < 0.01).

Conclusions

Treatment of pediatric NRSTS was variable, with large, deep, high‐grade tumors more likely to receive neoadjuvant and adjuvant treatments. Multidisciplinary treatment was associated with high rates of local control and durable survival. This study provides an extended follow‐up of pediatric patients to identify late complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaExtremitiesSoft Tissue NeoplasmsHumansChildFemaleMaleAdolescentNeoplasm Recurrence, LocalRetrospective StudiesFollow-Up StudiesSurvival RateChild, PreschoolCombined Modality TherapyTreatment Outcome

Stichwörter der Autor:innen

non‐rhabdomyosarcoma soft tissue sarcomapediatricpredictive factorssurvivaltreatment

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Mikaela H Sullivan, Lainey G Bukowiec, Wendy Allen-Rhoades, Peter J Schoettler, Nadia N Laack, Matthew T Houdek

Zitieren

APA

Sullivan, M. H., Bukowiec, L. G., Allen-Rhoades, W., Schoettler, P. J., Laack, N. N., Mahajan, A., Rose, P. S., & Houdek, M. T. (2026). Outcomes of Pediatric Non‐Rhabdomyosarcoma Soft‐Tissue Sarcomas of the Extremities. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70350

Vancouver

Sullivan MH, Bukowiec LG, Allen-Rhoades W, Schoettler PJ, Laack NN, Mahajan A, et al. Outcomes of Pediatric Non‐Rhabdomyosarcoma Soft‐Tissue Sarcomas of the Extremities. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70350

BibTeX
@article{Sullivan2026,
  author = {Sullivan, Mikaela H and Bukowiec, Lainey G and Allen-Rhoades, Wendy and Schoettler, Peter J and Laack, Nadia N and Mahajan, Anita and Rose, Peter S and Houdek, Matthew T},
  title = {Outcomes of Pediatric Non‐Rhabdomyosarcoma Soft‐Tissue Sarcomas of the Extremities},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70350}
}
Kostenlos starten →